Labat Africa (JSE:LAB) 1-Year Share Buyback Ratio: -91.80% (As of Nov. 2025 )

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Labat Africa 1-Year Share Buyback Ratio?

Labat Africa JSE:LAB 1-Year Share Buyback Ratio is -91.80 as of Nov. 2025. The stock has 5 warning signs investors should review. Among 491 Drug Manufacturers companies, Labat Africa ranks worse than 92.87% on this metric.

Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.

1-Year Share Buyback Ratio measures the proportion of a company's outstanding shares repurchased over the past year, calculated as the percentage change in shares outstanding from the previous year to the current year. A positive ratio may indicates share buybacks over the period, while a zero or negative ratio suggests no buybacks or potential share issuance. Labat Africa's current 1-Year Share Buyback Ratio was -91.80%.

JSE:LAB's 1-Year Share Buyback Ratio is ranked worse than
92.87% of 491 companies
in the Drug Manufacturers industry
Industry Median: -2 vs JSE:LAB: -91.80

Labat Africa  (JSE:LAB) 1-Year Share Buyback Ratio Explanation

A positive ratio may indicates share buybacks over the period, while a zero or negative ratio suggests no buybacks or potential share issuance.

Be Aware

Investors usually like share buybacks. But as pointed by Warren Buffett, only if a company buys back shares at the prices below the stock's intrinsic value, it rewards remaining shareholders. If a company buys its overvalued stocks back, it destroys shareholder value.

Labat Africa 1-Year Share Buyback Ratio Related Terms

JSE:LAB vs ZTS, UTHR, VTRS: 1-Year Share Buyback Ratio Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Labat Africa's 1-Year Share Buyback Ratio, along with its competitors' market caps and 1-Year Share Buyback Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Labat Africa 1-Year Share Buyback Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Labat Africa's 1-Year Share Buyback Ratio distribution charts can be found below:

* The bar in red indicates where Labat Africa's 1-Year Share Buyback Ratio falls into.


Labat Africa 1-Year Share Buyback Ratio Calculation

Labat Africa's 1-Year Share Buyback Ratio for the quarter that ended in Nov. 2025 is calculated as

1-Year Share Buyback Ratio=(Shares Outstanding (EOP) (Nov. 2024 ) - Shares Outstanding (EOP) (Nov. 2025 )) / Shares Outstanding (EOP) (Nov. 2024 )
=(649.556 - 1246.065) / 649.556
=-91.8%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a 1-Year Share Buyback Ratio of -91.80 mean?
Labat Africa (JSE:LAB) has a 1-Year Share Buyback Ratio of -91.80 as of Nov. 2025. The 1-Year Share Buyback Ratio measures the proportion of a company's outstanding shares repurchased over the past year, calculated as the percentage change in shares outstanding from the previous year to the current year. View historical data for Labat Africa and its competitors. According to the industry distribution chart, Labat Africa ranks #456 out of 491 companies in the Drug Manufacturers industry, placing it in the top 92.9%.
Is Labat Africa's 1-Year Share Buyback Ratio too high?
Labat Africa's current 1-Year Share Buyback Ratio is -91.80. Based on the distribution chart, Labat Africa ranks #456 out of 491 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers.
How does Labat Africa's 1-Year Share Buyback Ratio compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Labat Africa ranks #456 out of 491 companies for 1-Year Share Buyback Ratio. This places Labat Africa in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 1-Year Share Buyback Ratio for a Drug Manufacturers company?
A good 1-Year Share Buyback Ratio depends on the Drug Manufacturers industry context. However, 1-Year Share Buyback Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 1-Year Share Buyback Ratio mean?
A high 1-Year Share Buyback Ratio can signal that a stock is expensive relative to its fundamentals. The 1-Year Share Buyback Ratio measures the proportion of a company's outstanding shares repurchased over the past year, calculated as the percentage change in shares outstanding from the previous year to the current year. View historical data for Labat Africa and its competitors. Labat Africa's current 1-Year Share Buyback Ratio is -91.80. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Labat Africa stock overvalued right now?
Based on GuruFocus' analysis, Labat Africa (JSE:LAB) is currently considered Possible Value Trap. The stock's GF Value™ is R0.18, compared to a current price of R0.03 — trading 83.3% below its estimated fair value. The current 1-Year Share Buyback Ratio is -91.80. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 1-Year Share Buyback Ratio calculated?
1-Year Share Buyback Ratio is calculated from a company's financial statements. For Labat Africa (JSE:LAB), the current 1-Year Share Buyback Ratio is -91.80 as of Nov. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Labat Africa Business Description

Other Exchanges LAO:Germany
Address 75 Maude StreetSandown, The Leonardo 14th Floor, Sandown, Johannesburg, GT, ZAF, 1709
Labat Africa Ltd is an investment holding company. Through its subsidiaries, the company operates in the following segments; Technology, Head office, and Healthcare. The Technology segment manufactures and distributes integrated circuits South African Micro - Electronic Systems. Head office operations provide management services, logistics and seeks further investment opportunities for the Group. The Healthcare segment generates maximum revenue for the company and focusses on medical cannabis industry in South Africa. Geographically, the company carries out its business operations in South Africa.